Effects of metoprolol and ramipril on action potentials after myocardial infarction in rats

European Journal of Pharmacology

Volumn 388, Issue 3, 2000, Pages 263-266

  Wagner, Kay Dietrich ^a   Kamkin, Andre ^a   Kiseleva, Irina ^a   Theres, Heinz ^a   Scholz, Holger ^a   Günther, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Action potential; Metoprolol; Myocardial infarction; Papillary muscle; Ramipril

Indexed keywords

METOPROLOL; RAMIPRIL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART INFARCTION; HEART PAPILLARY MUSCLE; HEART REPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ACTION POTENTIALS; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ELECTRIC STIMULATION; HEART; MALE; METOPROLOL; MYOCARDIAL INFARCTION; RAMIPRIL; RATS; RATS, WISTAR;

EID: 0033968839     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00787-6     Document Type: Article

References (13)

1. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828. [see comments].
2. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc. Res. 28:1994;933-946.
3. Hjalmarson A., Herlitz J., Holmberg S., Ryden L., Swedberg K., Vedin A., Waagstein F., Waldenstrom A., Waldenstrom J., Wedel H., Wilhelmsen L., Wilhelmsson C. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation. 67:1983;I26-I32.
4. Kiseleva I., Kamkin A., Pylaev A., Kondratjev D., Leiterer K.P., Theres H., Wagner K.D., Persson P.B., Günther J. Electrophysiological properties of mechanosensitive atrial fibroblasts from chronic infarcted rat heart. J. Mol. Cell. Cardiol. 30:1998;1083-1093.
5. Nagasawa K., Zimmermann R., Munkel B., Linz W., Scholkens B., Schaper J. Extracellular matrix deposition in hypertensive hearts antifibrotic effects of ramipril. Eur. Heart J. 16(Suppl. C):1995;33-37.
6. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., Braunwald E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44:1979;503-512.
7. + currents in myocytes from epicardial border zone of the infarcted heart. Circ. Res. 81:1997;110-119.
8. Qin D., Zhang Z.H., Caref E.B., Boutjdir M., Jain P., el Sherif N. Cellular and ionic basis of arrhythmias in postinfarction remodeled ventricular myocardium. Circ. Res. 79:1996;461-473.
9. Raine A.E., Vaughan Williams E.M. Adaptation to prolonged beta-blockade of rabbit atrial, purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation. Circ. Res. 48:1981;804-812.
10. Vogt M., Motz W., Strauer B.E. Long-term treatment in arterial hypertension for protecting hypertrophic myocardium. Basic Res. Cardiol. 86(Suppl. 3):1991;223-233.
11. Wagner K.D., Theres H., Born A., Strube S., Wunderlich N., Pfitzer G., Baumann G., Günther J. Contractile function of papillary muscle from rats with different infarct size after β-adrenergic blockade and ACE-inhibition. J. Mol. Cell. Cardiol. 29:1997;2941-2951.
12. Wagner K.D., Geil D., Schimke I., Stauss H.M., Lammerich A., Theres H., Pfitzer G., Vetter R., Günther J. Decreased susceptibility of contractile function to hypoxia/reoxygenation in chronic infarcted rat hearts. J. Mol. Cell. Cardiol. 30:1998;2341-2353.
13. 2+ exchanger genes between adjacent and remote noninfarcted myocardium after myocardial infarction. J. Mol. Cell. Cardiol. 29:1997;255-264.